Literature DB >> 27402112

Juvenile Spondyloarthropathies.

Amra Adrovic1, Kenan Barut1, Sezgin Sahin1, Ozgur Kasapcopur2.   

Abstract

Juvenile spondyloarthropathies represent a clinical entity separate from the adult disease. Initial clinical signs of juvenile spondyloarthropathies often include lower extremity arthritis and enthesopathy, without axial involvement at the disease onset. Asymmetrical oligoarthritis of lower extremities is typically seen in this type of arthritis. Enthesopathy, which is the hallmark of the disease, is most commonly seen in the Achilles tendon, being manifested by heel pain. Anterior uveitis and HLA-B27 positivity are seen in a proportion of cases. Sacroiliitis is generally asymptomatic in the pediatric population. Ineffective treatment of childhood disease results in disease progression to typical adult form of ankylosing spondylitis. Therefore, early diagnosis and classification remains one of the most relevant questions in pediatric rheumatology. It should be kept in mind that the disease could be misdiagnosed as FMF or Behçet's syndrome in countries with a high incidence of those conditions. This review revises available classification criteria, clinical manifestations and therapeutic options for patients with juvenile spondyloarthropathies.

Entities:  

Keywords:  Enthesitis-related arthritis; Enthesopathy; HLA-B27; Juvenile spondyloarthropathies

Mesh:

Substances:

Year:  2016        PMID: 27402112     DOI: 10.1007/s11926-016-0603-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  53 in total

1.  Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.

Authors:  Alain Saraux; Jacques Benichou; Loic Guillevin; Latifa Idbrik; Chantal Job-Deslandre; Jean Sibilia; Marc Soudant; Daniel Wendling; Francis Guillemin
Journal:  Clin Exp Rheumatol       Date:  2015-08-27       Impact factor: 4.473

2.  Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis.

Authors:  Ozgür Kasapçopur; Nail Yologlu; Yilmaz Ozyazgan; Gökmen Ercan; Salim Caliskan; Lale Sever; Huri Ozdogan; Nil Arisoy
Journal:  Indian Pediatr       Date:  2004-10       Impact factor: 1.411

3.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

Review 4.  Genetics of spondyloarthritis--beyond the MHC.

Authors:  John D Reveille
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

5.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

6.  Tarsitis as an initial manifestation of juvenile spondyloarthropathy.

Authors:  C Alvarez-Madrid; R Merino; J De Inocencio; J García-Consuegra
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

7.  Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors:  Pamela F Weiss; Timothy Beukelman; Laura E Schanberg; Yukiko Kimura; Robert A Colbert
Journal:  J Rheumatol       Date:  2012-10-15       Impact factor: 4.666

8.  HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis.

Authors:  Lillemor Berntson; Michael Damgård; Boel Andersson-Gäre; Troels Herlin; Susan Nielsen; Ellen Nordal; Marite Rygg; Marek Zak; Anders Fasth
Journal:  J Rheumatol       Date:  2008-09-01       Impact factor: 4.666

9.  Inflammatory changes of the lumbar spine in children and adolescents with enthesitis-related arthritis: magnetic resonance imaging findings.

Authors:  Kanimozhi Vendhan; Debajit Sen; Corinne Fisher; Yiannis Ioannou; Margaret A Hall-Craggs
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-01       Impact factor: 4.794

10.  Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial.

Authors:  Iain B McInnes; Joachim Sieper; Jürgen Braun; Paul Emery; Désirée van der Heijde; John D Isaacs; Georg Dahmen; Jürgen Wollenhaupt; Hendrik Schulze-Koops; Joseph Kogan; Shenglin Ma; Martin M Schumacher; Arthur P Bertolino; Wolfgang Hueber; Paul P Tak
Journal:  Ann Rheum Dis       Date:  2013-01-29       Impact factor: 19.103

View more
  10 in total

1.  Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis.

Authors:  Ayşenur Paç Kısaarslan; Betül Sözeri; Zübeyde Gündüz; Gökmen Zararsız; Hakan Poyrazoğlu; Ruhan Düşünsel
Journal:  Eur J Rheumatol       Date:  2019-04-22

2.  The performance of classification criteria for juvenile spondyloarthropathies.

Authors:  Amra Adrovic; Metin Sezen; Kenan Barut; Sezgin Sahin; Cengizhan Acikel; Erkan Demirkaya; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2017-10-10       Impact factor: 2.631

3.  The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?

Authors:  Ilaria Pagnini; Mariangela Scavone; Ilaria Maccora; Maria Vincenza Mastrolia; Edoardo Marrani; Federico Bertini; Lovro Lamot; Gabriele Simonini
Journal:  Front Med (Lausanne)       Date:  2021-05-13

4.  Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches.

Authors:  Sabrina Gmuca; Rui Xiao; Timothy G Brandon; Ilaria Pagnini; Tracey B Wright; Timothy Beukelman; Esi M Morgan; Pamela F Weiss
Journal:  Arthritis Res Ther       Date:  2017-05-02       Impact factor: 5.156

5.  Juvenile Idiopathic Arthritis.

Authors:  Kenan Barut; Amra Adrovic; Sezgin Şahin; Özgür Kasapçopur
Journal:  Balkan Med J       Date:  2017-04-05       Impact factor: 2.021

6.  The LMP2 CfoI polymorphism is associated with ankylosing spondylitis (AS) risk but not with acute anterior uveitis (AAU): A meta-analysis.

Authors:  Yufeng Qian; Bingqian Chen; Xiaowen Sheng; Yuqin Peng
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 7.  Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection.

Authors:  Chengappa G Kavadichanda; Jie Geng; Sree Nethra Bulusu; Vir Singh Negi; Malini Raghavan
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

8.  Joint involvement, disease activity and quality of life in pediatric Crohn's disease - a cross-sectional study.

Authors:  Beata Derfalvi; Kriszta Katinka Boros; Doloresz Szabo; Gabor Bozsaki; Aron Cseh; Gabor Rudas; Katalin Eszter Muller; Gabor Veres
Journal:  Pediatr Rheumatol Online J       Date:  2022-01-29       Impact factor: 3.054

9.  Update on the management of uveitis in children: an overview for the clinician.

Authors:  Lucas Kim; Alexa Li; Sheila Angeles-Han; Steven Yeh; Jessica Shantha
Journal:  Expert Rev Ophthalmol       Date:  2019-09-19

10.  Classifications and imaging of juvenile spondyloarthritis.

Authors:  Iwona Sudoł-Szopińska; Iris Eshed; Lennart Jans; Nele Herregods; James Teh; Jelena Vojinovic
Journal:  J Ultrason       Date:  2018
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.